Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study

DOI: 10.1186/s40880-018-0303-2

Keywords: Non-small cell lung cancer, Epidermal growth factor receptor, T790M, ctDNA, Failure sites

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s40880-018-0303-2) contains supplementary material, which is available to authorized users

Full-Text